Back
EyePoint Pharmaceuticals Stock Predictions
Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
EYPT
EyePoint Pharmaceuticals
Last Price:
$6.25
Seasonality Move:
16.96%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.EyePoint Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 44.3% based on the past 20 years of stock performance.
-
EyePoint Pharmaceuticals has risen higher in 7 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 35%
-
Is EyePoint Pharmaceuticals Stock Undervalued?The current EyePoint Pharmaceuticals [EYPT] share price is $6.23. The Score for EYPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will EyePoint Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 44.3% based on the past 20 years of stock performance.
EyePoint Pharmaceuticals Stock Rating
Sell
32
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals overpriced?
-
EyePoint Pharmaceuticals has risen higher in 7 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 35%
EyePoint Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
eyepointpharma.com
52-Week Data
52-Week High:
23.65
52-Week Low:
5.54
Prediction Charts
Market Cap:
428.2M
Price in USD:
6.23
Volume:
1.1M
Beta:
1.88
Technical Analysis
SMA50:
7.00
SMA100:
8.09
SMA200:
8.51
52-Wk Change:
-73.4%
Stock Predictions
-
Is EyePoint Pharmaceuticals stock public?Yes, EyePoint Pharmaceuticals is a publicly traded company.
-
What is the EyePoint Pharmaceuticals stock quote today?The EyePoint Pharmaceuticals stock price is 6.23 USD today.
-
How to buy EyePoint Pharmaceuticals stock online?You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-4 | 5.54 | 6.08 | 6.31 | 5.54 |
| Mar-5 | 6.33 | 6.58 | 6.61 | 5.94 |
| Mar-6 | 6.33 | 6.82 | 6.90 | 6.25 |
| Mar-7 | 6.82 | 7.13 | 7.45 | 6.71 |
| Mar-10 | 6.98 | 7.09 | 7.19 | 6.77 |
| Mar-11 | 7.09 | 7.35 | 7.50 | 6.80 |
| Mar-12 | 7.35 | 7.33 | 7.61 | 7.08 |
| Mar-13 | 7.36 | 6.83 | 7.58 | 6.78 |
| Mar-14 | 6.83 | 6.52 | 7.06 | 6.44 |
| Mar-17 | 6.64 | 6.63 | 6.69 | 6.33 |
| Mar-18 | 6.60 | 6.21 | 6.63 | 6.21 |
| Mar-19 | 6.18 | 6.19 | 6.31 | 6.00 |
| Mar-20 | 6.12 | 6.10 | 6.30 | 5.98 |
| Mar-21 | 6.00 | 6.23 | 6.39 | 5.93 |
EyePoint Pharmaceuticals Earnings
EyePoint Pharmaceuticals Earnings Report: Per Share EyePoint Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
EyePoint Pharmaceuticals Forecast Revenue Growth
EyePoint Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.